EUVIMEDEUVIMED entdecken
Crossref

CXCR2 promotes tacrolimus-related cardiotoxicity via activating the Src-mediated PI3K/Akt/mTOR pathway

Xiao Chen, Ke Hu, Yue Zhang, Jie Wang, Su-Mei He, Yang Yang, Dong-Dong Wang

International Immunopharmacology · 2026-05 · 177 · 116527

DOI: 10.1016/j.intimp.2026.116527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-05. Verfasst von Xiao Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China. Hauptthemen laut MEDLINE: Tacrolimus, Cardiotoxicity, Receptors, Interleukin-8B, Immunosuppressive Agents. Die Arbeit nennt 71 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Natural Science Research of Jiangsu Higher Education Institutions of China, Research and Innovation in Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tacrolimus is produced through fermentation by the Streptomyces tsukubaensis strain and its related cardiotoxicity is a clinical problem that can not be ignored and needs to be solved in pediatric patients. However, the mechanism of tacrolimus-related cardiotoxicity in pediatric patients remain unknown. This study aims to explore potential drug targets for tacrolimus-related cardiotoxicity and conduct experimental therapeutic research. Transcriptomics, bioinformatics, molecular biology, pathological staining were used to explore potential drug targets for tacrolimus-related cardiotoxicity in wistar rats and knockout mice. In the animal models of tacrolimus-related cardiotoxicity, myocardial fibrosis and epithelial-mesenchymal transition (EMT) occurred and CXCR2, Src-mediated PI3K/Akt/mTOR pathway were activated (P < 0.05 or P < 0.01). CXCR2 antagonist or CXCR2 knockout inactivated Src-mediated PI3K/Akt/mTOR pathway, meanwhile alleviated myocardial fibrosis and EMT (P < 0.05 or P < 0.01). The present study demonstrates that CXCR2 promotes tacrolimus-related cardiotoxicity via activating the Src-mediated PI3K/Akt/mTOR pathway for the first time. CXCR2 antagonist may be used as intervention for potential tacrolimus-related cardiotoxicity via inactivating the Src-mediated PI3K/Akt/mTOR pathway to alleviate myocardial fibrosis and reverse myocardial EMT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusCardiotoxicityReceptors, Interleukin-8BImmunosuppressive AgentsAnimalsTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktSignal TransductionPhosphatidylinositol 3-KinasesRats, WistarMaleMiceMice, KnockoutRatsEpithelial-Mesenchymal TransitionMyocardiumsrc-Family Kinases

Stichwörter der Autor:innen

CXCR2CardiotoxicityPI3K/Akt/mTORSrcTacrolimus

Substanzen

TacrolimusTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesReceptors, Interleukin-8BImmunosuppressive AgentsCxcr2 protein, mousesrc-Family Kinases

Autor:innen und Institutionen

  • School of Nursing, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy & School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; Department of Pharmacy, Ezhou Central Hospital, Ezhou, Hubei 436000, Chin…
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy & School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
  • Department of Pharmacy, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu 215153, China. Electronic address: hehe8204@163.com.
  • Department of Pharmacy, The Affiliated Changzhou Children's Hospital of Nantong University, Changzhou, Jiangsu 213002, China. Electronic address: m15952155711_1@163.com.
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy & School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China. Electronic address: 13852029591@163.com.

Förderung

  • Natural Science Foundation of Jiangsu Province
  • Natural Science Research of Jiangsu Higher Education Institutions of China
  • Research and Innovation in Science and Technology Project
  • Xuzhou Science and Technology Program
  • Jiangsu Commission of Health

Zitieren

APA

Chen, X., Hu, K., Zhang, Y., Wang, J., He, S. M., Yang, Y., & Wang, D. D. (2026). CXCR2 promotes tacrolimus-related cardiotoxicity via activating the Src-mediated PI3K/Akt/mTOR pathway. International Immunopharmacology, 177, 116527. https://doi.org/10.1016/j.intimp.2026.116527

Vancouver

Chen X, Hu K, Zhang Y, Wang J, He SM, Yang Y, et al. CXCR2 promotes tacrolimus-related cardiotoxicity via activating the Src-mediated PI3K/Akt/mTOR pathway. International Immunopharmacology. 2026;177:116527. doi:10.1016/j.intimp.2026.116527

BibTeX
@article{Chen2026,
  author = {Chen, Xiao and Hu, Ke and Zhang, Yue and Wang, Jie and He, Su-Mei and Yang, Yang and Wang, Dong-Dong},
  title = {CXCR2 promotes tacrolimus-related cardiotoxicity via activating the Src-mediated PI3K/Akt/mTOR pathway},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {177},
  pages = {116527},
  doi = {10.1016/j.intimp.2026.116527}
}
Kostenlos starten →